Federal Circuit Slams Purdue With Inequitable Conduct Finding In OxyContent Patent Suit

Law360 (June 7, 2005, 12:00 AM EDT) -- In a major setback for Purdue Pharma, Endo Pharmaceutical Holdings Inc. has won an appeals court ruling allowing it to sell a generic version of the painkiller OxyContin.

The U.S. Court of Appeals for the Federal Circuit upheld a decision that three patents held by Purdue Pharma LP are unenforceable due to inequitable conduct before the U.S. Patent and Trademark Office.

The decision upholds a January 2004 ruling from U.S. District Court Judge Sidney Stein with the Southern District of New York.

Judge Stein found that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.